Analysis for Boston Scientific
Description & usage
Boston Scientific develops medical devices across cardiology, endoscopy, and neuromodulation categories. The company benefits from a strong innovation pipeline and structural growth in global healthcare demand. Key drivers are product launches, procedure volumes, price/mix, and operating margins.
Basic info
- Symbol
- BSX
- Type
- Stock
- Region
- US
- Sector
- Health Care
- Available history
- 11.2 years
- Last trading day
- 04/02/2026
Basic info
- Symbol
- BSX
- Type
- Stock
- Region
- US
- Sector
- Health Care
- Available history
- 11.2 years
- Last trading day
- 04/02/2026
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- CPI YoY
- 2.4%
- Fed Rate
- 3.75%
- US 10Y
- 4.35%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core CPI
- 2.5%
- US 2Y
- 3.84%
- ISM PMI
- –
Score overview
The overall score combines Performance, Stability and Trend into one comparable value.
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- CPI YoY
- 2.4%
- Fed Rate
- 3.75%
- US 10Y
- 4.35%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core CPI
- 2.5%
- US 2Y
- 3.84%
- ISM PMI
- –
Analysis summary
Technical asset picture
Boston Scientific (BSX) currently has a total score of 42 points, placing it in the neutral range. The score is made up of Performance (59), Stability (40) and Trend (4). The profile is clearly uneven: Performance stands out while Trend lags.
Performance scores 59 points (neutral). Key strength: 10Y return at 250.4 %. Weaker metric: 1Y return at -37.9 %. This suggests stronger long-term than short-term performance.
Stability scores 40 points (neutral). Best-ranked metric: max drawdown (10Y) at -43.5 %. Weaker metric: Sharpe ratio (90d) at -1.45. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns-but prices can still fall.
Trend scores 4 points (very weak). Trend signals are mostly negative right now. Least weak metric: 12M momentum at -28.7 %. Main drag: Price is about 27.1 % below SMA100.
Overall, the picture is mixed: Performance does the heavy lifting while Trend holds the score back. On a metric level, max drawdown (10Y) stands out, while Sharpe ratio (90d) is the main weak spot.
Current market backdrop
The backdrop currently looks mixed and rather restrictive.
A strong US dollar currently paints a mixed risk picture.
High US real yields and elevated long yields lean toward a restrictive rate backdrop.
What that typically means here
For this asset type, the current backdrop looks mixed rather than clearly directional.
Note: ISM PMI was not used actively in the effect logic.
Historical evaluation and qualitative market context only, not investment advice.
Price chart
Use the chart to read recent price behavior before drilling into metrics.
Scores and metrics
Explore the overall score, the three pillar scores, and the metrics behind them.